Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy
Schizophrenia is a severe psychiatric disorder that involves positive, negative and cognitive symptoms. Prepulse inhibition of startle reflex (PPI) is a paradigm that assesses the sensorimotor gating functioning and is impaired in schizophrenia patients as well as in animal models of this disorder....
Saved in:
Main Authors: | Fernanda Fiel Peres (Author), Raquel Levin (Author), Valéria Almeida (Author), Antonio Waldo Zuardi (Author), Jaime E Hallak (Author), José Alexandre Crippa (Author), Vanessa Costhek Abilio (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Cannabinoid Drugs on the Deficit of Prepulse Inhibition of Startle in an Animal Model of Schizophrenia: the SHR Strain
by: Raquel eLevin, et al.
Published: (2014) -
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
by: Cássio Morais Loss, et al.
Published: (2021) -
Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
by: Fernanda Fiel Peres, et al.
Published: (2016) -
∆9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
by: José Alexandre Crippa, et al.
Published: (2016) -
Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
by: Fernanda F. Peres, et al.
Published: (2018)